Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Lessons learned conducting a multi-center trial with a military population: The Tinnitus Retraining Therapy Trial.

Scherer RW, Sensinger LD, Sierra-Irizarry B, Formby C; TRTT Research Group.

Clin Trials. 2018 May 1:1740774518777709. doi: 10.1177/1740774518777709. [Epub ahead of print]

PMID:
29792074
2.

The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial.

Scherer RW, Drye L, Mintzer J, Lanctôt K, Rosenberg P, Herrmann N, Padala P, Brawman-Mintzer O, Burke W, Craft S, Lerner AJ, Levey A, Porsteinsson A, van Dyck CH; ADMET 2 Research Group.

Trials. 2018 Jan 18;19(1):46. doi: 10.1186/s13063-017-2406-5.

3.

CONSORT 2010 statement: extension checklist for reporting within person randomised trials.

Pandis N, Chung B, Scherer RW, Elbourne D, Altman DG.

BMJ. 2017 Jun 30;357:j2835. doi: 10.1136/bmj.j2835. No abstract available.

4.

The Emergence of Systematic Review in Toxicology.

Stephens ML, Betts K, Beck NB, Cogliano V, Dickersin K, Fitzpatrick S, Freeman J, Gray G, Hartung T, McPartland J, Rooney AA, Scherer RW, Verloo D, Hoffmann S.

Toxicol Sci. 2016 Jul;152(1):10-6. doi: 10.1093/toxsci/kfw059. Epub 2016 May 5.

5.

Dependability of results in conference abstracts of randomized controlled trials in ophthalmology and author financial conflicts of interest as a factor associated with full publication.

Saldanha IJ, Scherer RW, Rodriguez-Barraquer I, Jampel HD, Dickersin K.

Trials. 2016 Apr 26;17(1):213. doi: 10.1186/s13063-016-1343-z.

6.

Using ClinicalTrials.gov to supplement information in ophthalmology conference abstracts about trial outcomes: a comparison study.

Scherer RW, Huynh L, Ervin AM, Dickersin K.

PLoS One. 2015 Jun 24;10(6):e0130619. doi: 10.1371/journal.pone.0130619. eCollection 2015.

8.

Authors report lack of time as main reason for unpublished research presented at biomedical conferences: a systematic review.

Scherer RW, Ugarte-Gil C, Schmucker C, Meerpohl JJ.

J Clin Epidemiol. 2015 Jul;68(7):803-10. doi: 10.1016/j.jclinepi.2015.01.027. Epub 2015 Feb 13. Review.

9.

The effectiveness of exercise interventions for improving health-related quality of life from diagnosis through active cancer treatment.

Mishra SI, Scherer RW, Snyder C, Geigle P, Gotay C.

Oncol Nurs Forum. 2015 Jan;42(1):E33-53. doi: 10.1188/15.ONF.E33-E53. Review.

PMID:
25542333
10.

Extent of non-publication in cohorts of studies approved by research ethics committees or included in trial registries.

Schmucker C, Schell LK, Portalupi S, Oeller P, Cabrera L, Bassler D, Schwarzer G, Scherer RW, Antes G, von Elm E, Meerpohl JJ; OPEN consortium.

PLoS One. 2014 Dec 23;9(12):e114023. doi: 10.1371/journal.pone.0114023. eCollection 2014.

11.

Are exercise programs effective for improving health-related quality of life among cancer survivors? A systematic review and meta-analysis.

Mishra SI, Scherer RW, Snyder C, Geigle P, Gotay C.

Oncol Nurs Forum. 2014 Nov 1;41(6):E326-42. doi: 10.1188/14.ONF.E326-E342. Review.

12.

The Tinnitus Retraining Therapy Trial (TRTT): study protocol for a randomized controlled trial.

Scherer RW, Formby C, Gold S, Erdman S, Rodhe C, Carlson M, Shade D, Tucker M, Sensinger LM, Hughes G, Conley GS, Downey N, Eades C, Jylkka M, Haber-Perez A, Harper C, Russell SK, Sierra-Irizarry B, Sullivan M; Tinnitus Retraining Therapy Trial Research Group.

Trials. 2014 Oct 15;15:396. doi: 10.1186/1745-6215-15-396.

13.

Spectacle correction versus no spectacles for prevention of strabismus in hyperopic children.

Jones-Jordan L, Wang X, Scherer RW, Mutti DO.

Cochrane Database Syst Rev. 2014 Aug 18;(8):CD007738. doi: 10.1002/14651858.CD007738.pub2. Review.

14.

Medical interventions for traumatic hyphema.

Gharaibeh A, Savage HI, Scherer RW, Goldberg MF, Lindsley K.

Cochrane Database Syst Rev. 2013 Dec 3;(12):CD005431. doi: 10.1002/14651858.CD005431.pub3. Review.

15.

Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial.

Lanctôt KL, Chau SA, Herrmann N, Drye LT, Rosenberg PB, Scherer RW, Black SE, Vaidya V, Bachman DL, Mintzer JE.

Int Psychogeriatr. 2014 Feb;26(2):239-46. doi: 10.1017/S1041610213001762. Epub 2013 Oct 29.

16.

A survey of frameworks for best practices in weight-of-evidence analyses.

Rhomberg LR, Goodman JE, Bailey LA, Prueitt RL, Beck NB, Bevan C, Honeycutt M, Kaminski NE, Paoli G, Pottenger LH, Scherer RW, Wise KC, Becker RA.

Crit Rev Toxicol. 2013 Oct;43(9):753-84. doi: 10.3109/10408444.2013.832727. Review.

PMID:
24040995
17.

Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.

Rosenberg PB, Lanctôt KL, Drye LT, Herrmann N, Scherer RW, Bachman DL, Mintzer JE, ADMET Investigators.

J Clin Psychiatry. 2013 Aug;74(8):810-6. doi: 10.4088/JCP.12m08099.

18.

ClinicalTrials.gov registration can supplement information in abstracts for systematic reviews: a comparison study.

Scherer RW, Huynh L, Ervin AM, Taylor J, Dickersin K.

BMC Med Res Methodol. 2013 Jun 18;13:79. doi: 10.1186/1471-2288-13-79.

19.

Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET).

Drye LT, Scherer RW, Lanctôt KL, Rosenberg PB, Herrmann N, Bachman D, Mintzer JE; ADMET Research Group.

Am J Geriatr Psychiatry. 2013 Jun;21(6):549-59. doi: 10.1016/j.jagp.2012.12.018. Epub 2013 Jan 18.

20.

Evidence-based toxicology: strait is the gate, but the road is worth taking.

Silbergeld E, Scherer RW.

ALTEX. 2013;30(1):67-73.

PMID:
23338807

Supplemental Content

Loading ...
Support Center